M & A Law Prof Blog

Editor: Brian JM Quinn
Boston College Law School

Wednesday, March 30, 2011

Sanofi/Genzyme CVRs

... to start trading on April 4?  So says Reuters:

The French drugmaker said on Tuesday that the U.S. Securities and Exchange Commission (SEC) had cleared the trading of contingent value rights (CVR) under the ticker GCVRZ.O.



| Permalink

TrackBack URL for this entry:


Listed below are links to weblogs that reference Sanofi/Genzyme CVRs:


Post a comment